Clinical Trial Update: Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very High-Risk MDS Patients Based on IPSS-M Stratification [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating a prophylactic intervention to prevent relapse after allogeneic transplantation in very high-risk myelodysplastic syndromes, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Myelodysplastic Syndromes, Adult | Phase 2 | Status: RECRUITING